BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 20711206)

  • 1. X-linked inhibitor of apoptosis protein as a therapeutic target in metastatic melanoma.
    Tian F; Lee SW
    J Invest Dermatol; 2010 Sep; 130(9):2169-72. PubMed ID: 20711206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting X-linked inhibitor of apoptosis protein to increase the efficacy of endoplasmic reticulum stress-induced apoptosis for melanoma therapy.
    Hiscutt EL; Hill DS; Martin S; Kerr R; Harbottle A; Birch-Machin M; Redfern CP; Fulda S; Armstrong JL; Lovat PE
    J Invest Dermatol; 2010 Sep; 130(9):2250-8. PubMed ID: 20520630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunity to X-linked inhibitor of apoptosis protein (XIAP) in malignant melanoma and check-point blockade.
    Zhou J; Li J; Guleria I; Chen T; Giobbie-Hurder A; Stevens J; Gupta M; Wu X; Brennick RC; Manos MP; Hodi FS
    Cancer Immunol Immunother; 2019 Aug; 68(8):1331-1340. PubMed ID: 31317218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smac mimetic reverses resistance to TRAIL and chemotherapy in human urothelial cancer cells.
    Metwalli AR; Khanbolooki S; Jinesh G; Sundi D; Shah JB; Shrader M; Choi W; Lashinger LM; Chunduru S; McConkey DJ; McKinlay M; Kamat AM
    Cancer Biol Ther; 2010 Nov; 10(9):885-92. PubMed ID: 20814238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of XIAP expression in DLBCL and effect of its inhibition on AKT signalling.
    Hussain AR; Uddin S; Ahmed M; Bu R; Ahmed SO; Abubaker J; Sultana M; Ajarim D; Al-Dayel F; Bavi PP; Al-Kuraya KS
    J Pathol; 2010 Oct; 222(2):180-90. PubMed ID: 20632385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting x-linked inhibitor of apoptosis protein for melanoma therapy: the need for more homogeneous samples and the importance of cell lines.
    Kwatra SG
    J Invest Dermatol; 2011 Mar; 131(3):797. PubMed ID: 21068753
    [No Abstract]   [Full Text] [Related]  

  • 7. X-linked inhibitor of apoptosis: a chemoresistance factor or a hollow promise.
    Kashkar H
    Clin Cancer Res; 2010 Sep; 16(18):4496-502. PubMed ID: 20682709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. XIAP associated factor 1 (XAF1) represses expression of X-linked inhibitor of apoptosis protein (XIAP) and regulates invasion, cell cycle, apoptosis, and cisplatin sensitivity of ovarian carcinoma cells.
    Zhao WJ; Deng BY; Wang XM; Miao Y; Wang JN
    Asian Pac J Cancer Prev; 2015; 16(6):2453-8. PubMed ID: 25824780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. X-linked inhibitor of apoptosis protein as a therapeutic target.
    Dean EJ; Ranson M; Blackhall F; Dive C
    Expert Opin Ther Targets; 2007 Nov; 11(11):1459-71. PubMed ID: 18028010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The X-linked inhibitor of apoptosis protein (XIAP) is involved in melanoma invasion by regulating cell migration and survival.
    Ayachi O; Barlin M; Broxtermann PN; Kashkar H; Mauch C; Zigrino P
    Cell Oncol (Dordr); 2019 Jun; 42(3):319-329. PubMed ID: 30778852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. XIAP downregulation accompanies mebendazole growth inhibition in melanoma xenografts.
    Doudican NA; Byron SA; Pollock PM; Orlow SJ
    Anticancer Drugs; 2013 Feb; 24(2):181-8. PubMed ID: 23059386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of ω-3 fatty acids and cisplatin as a potential alternative strategy for personalized therapy of metastatic melanoma: an in-vitro study.
    Ottes Vasconcelos R; Serini S; de Souza Votto AP; Santos Trindade G; Fanali C; Sgambato A; Calviello G
    Melanoma Res; 2019 Jun; 29(3):270-280. PubMed ID: 30550405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by Phenoxodiol is associated with Carboplatin sensitization.
    Kluger HM; McCarthy MM; Alvero AB; Sznol M; Ariyan S; Camp RL; Rimm DL; Mor G
    J Transl Med; 2007 Jan; 5():6. PubMed ID: 17257402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitization of melanoma cells to TRAIL by UVB-induced and NF-kappaB-mediated downregulation of xIAP.
    Thayaparasingham B; Kunz A; Peters N; Kulms D
    Oncogene; 2009 Jan; 28(3):345-62. PubMed ID: 18978816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting X chromosome-linked inhibitor of apoptosis protein in mucoepidermoid carcinoma of the head and neck: A novel therapeutic strategy using nitidine chloride.
    Kwon HJ; Yoon K; Jung JY; Ryu MH; Kim SH; Yoo ES; Choi SY; Yang IH; Hong SD; Shin JA; Cho SD
    J Mol Med (Berl); 2020 Nov; 98(11):1591-1602. PubMed ID: 32901343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis and melanoma: how new insights are effecting the development of new therapies for melanoma.
    Hersey P
    Curr Opin Oncol; 2006 Mar; 18(2):189-96. PubMed ID: 16462190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53.
    Bush JA; Cheung KJ; Li G
    Exp Cell Res; 2001 Dec; 271(2):305-14. PubMed ID: 11716543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caspase-3 cleaves XIAP in a positive feedback loop to sensitize melanoma cells to TRAIL-induced apoptosis.
    Hörnle M; Peters N; Thayaparasingham B; Vörsmann H; Kashkar H; Kulms D
    Oncogene; 2011 Feb; 30(5):575-87. PubMed ID: 20856198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New drug targets in metastatic melanoma.
    Homet B; Ribas A
    J Pathol; 2014 Jan; 232(2):134-41. PubMed ID: 24027077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. XIAP-targeting drugs re-sensitize PIK3CA-mutated colorectal cancer cells for death receptor-induced apoptosis.
    Ehrenschwender M; Bittner S; Seibold K; Wajant H
    Cell Death Dis; 2014 Dec; 5(12):e1570. PubMed ID: 25501831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.